Recent News

• 05.12.2025 - Akoya Biosciences Reports First Quarter 2025 Financial Results
• 04.29.2025 - Quanterix and Akoya Biosciences Announce Amended Merger Agreement
• 04.24.2025 - Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025
• 04.24.2025 - Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas
• 04.23.2025 - Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore

Recent Filings

• 05.12.2025 - 8-K Current report
• 05.12.2025 - EX-99.1 EX-99.1
• 05.12.2025 - 425 Prospectuses and communications, business combinations
• 05.12.2025 - 425 Prospectuses and communications, business combinations
• 04.30.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 04.30.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 04.29.2025 - 425 Prospectuses and communications, business combinations
• 04.29.2025 - 8-K Current report
• 04.29.2025 - EX-99.1 EX-99.1
• 04.29.2025 - 425 Prospectuses and communications, business combinations